Table 1.
FCAS | MWS | CINCA/NOMID | DFN34 | KFH | |
---|---|---|---|---|---|
Attack pattern | Recurrent Lasting <24 hours Precipitated by cold exposure |
Recurrent Lasting 1 to 3 days |
Recurrent-to-continuous 1-to-3 flares per day |
Sub-clinical Progressive |
Recurrent, unilateral Lasting 24-48 hours Improvement with age |
Urticaria-like rash
(during the attacks) |
+ | + | + | – | – |
Fever/chills/arthralgias
(during the attacks) |
+ | + | + | – | – |
Headache
(during the attacks) |
+ | + | + | – | – |
Amyloidosis | Rare | + (late-onset) | – | – | – |
Sensorineural hearing loss | Rare | + (progressive) | Yes | + (bilateral, progressive) |
– |
Ocular symptoms | Keratitis- conjunctivitis |
Keratitis- conjunctivitis |
Anterior Uveitis Visual loss (due to chronic papilledema) |
– | Keratitis Photophobia Peri-corneal and peri-conjunctival injection Red and painful eye Blurry vision after the attacks Reduced visual acuity (long-term) |
CNS involvement | – | – | Chronic aseptic meningitis Hydrocephalus Papilledema Intellectual disability |
– | – |
Osteoarticular involvement | – | – | Destructive arthropathy | – | – |
FCAS, Familial cold autoinflammatory syndrome; MWS Muckle Wells Syndrome; CINCA/NOMID, chronic infantile neurologic, cutaneous, and articular syndrome/neonatal-onset multisystem inflammatory disease; DFN34, Deafness Autosomal Dominant 34; KFH, Keratitis Fugax Hereditaria; CNS, Central nervous system. The symbol “+” corresponds to the presence of clinical features, while the symbol “-” corresponds to their absence.